Background In 2020, China proposed the goals \”to peak carbon dioxide emissions by 2030 and to achieve carbon neutrality by 2060\”. In ord…
Background Generic drugs account for more than 90% of the marketed drugs in China. In 2012, China initiated the equivalence evaluation plan to require…
Background Since Circular No. 24/2019/TT-BYT on management and use of food additive by the Ministry of Health of Vietnam, international standard such …
Background Ingredient quality directly affects cosmetics\’ quality. Being keenly aware of this fact, regulatory departments around the world hav…
Background EU countries are China’s important traders of infant formula, supplying raw materials as well as finished products to China. In the past fe…
This is a collection of China\’s recent pharmaceutical laws, regulations, policies, and standards, mainly issued by the following authorities: N…
For frequently asked questions concerning technical issues, China Center for Drug Evaluation (CDE) releases corresponding answers on its website. For …
Editor\’s Notes: New drugs in this article refer to Innovative/improved new chemical drugs / biological products that have never been granted ma…
